Atlas Trials

Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)

Clinical trial NCT02797626 · UNKNOWN

Trial details

NCT number
NCT02797626
Sponsor
Heinrich-Heine University, Duesseldorf
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Stage II A/B Seminomatous Germ Cell Tumors
Start date
2016-06-01
Primary completion
2021-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.